ALPHS — Pharmasimple SA Balance Sheet
0.000.00%
TechnologyHighly SpeculativeMicro Cap
Annual balance sheet for Pharmasimple SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
C2016 December 31st  | 2017 December 31st  | 2018 December 31st  | 2019 December 31st  | 2020 December 31st  | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — | 
| Source: | ARS | ARS | ARS | ARS | ARS | 
| Standards: | BAS | BAS | BAS | BAS | BAS | 
| Status: | Final | Final | Final | Final | Final | 
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 1.01 | 3.82 | 1.92 | 4.4 | 3.7 | 
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 1.77 | 2.55 | 1.43 | 2.01 | 5.51 | 
| Total Inventory | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 4.71 | 10.3 | 6.89 | 11.3 | 14.3 | 
| Net Property, Plant And Equipment | 0.219 | 0.384 | 0.527 | 0.41 | 0.343 | 
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 5.66 | 12 | 10.5 | 21.4 | 23.3 | 
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 3.8 | 6.78 | 7.33 | 9 | 12.8 | 
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 5.03 | 7.71 | 8.72 | 14.5 | 17.9 | 
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 0.626 | 4.26 | 1.81 | 6.93 | 5.45 | 
| Total Liabilities & Shareholders' Equity | 5.66 | 12 | 10.5 | 21.4 | 23.3 | 
| Total Common Shares Outstanding |